The Weekly Litigation News Digest is now live. Subscribe now

Esperion Therapeutics competitive analysis

Loading summary...

Explore Esperion Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Nov 1, 2023Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular Risk6

Latest PTAB cases involving Esperion Therapeutics

Discover the latest PTAB cases involving Esperion Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Esperion Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ESPERION THERAPEUTICS - 6 - -
GALENICUM HEALTH SLU2713 - -
HOEFER & PARTNER PATENTANWALTE MBB13 - - -
INTAS PHARMACEUTICALS1643 -